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Executive Summary 
 
Here are a few points drawn from our HCV data: 
• 2,287 Iowans Diagnosed with HCV: In 2016, Iowa experienced the largest number of people 
diagnosed with hepatitis C since reporting began, including the largest number and proportion of 
people 30 and under who were diagnosed with HCV. There are several things that may have 
contributed to the overall increase in diagnoses. These include increased testing among baby 
boomers (those born between 1945 and 1965) and an expanding number of people who inject 
drugs related to the opioid epidemic. 
• Sex: Overall, nearly two-thirds (63%) of people diagnosed with HCV in 2016 were males. However, 
an analysis of people 30 and younger reported with HCV reveals that nearly half (48%) of them 
were female.  
• Birth Cohort: Fifty-five (55) percent of people diagnosed with HCV in 2016 were baby boomers, or 
those born between 1945 and 1965, while 15% were people born after 1986 (30 years of age and 
younger). About 30% of people diagnosed in 2016 were born between 1966 and 1985 (between 
the ages of 31 years old and 50 years old). A significantly smaller percentage (2%) of people 
reported with HCV in 2016 were born before 1945.  
• Race and Ethnicity: Unlike HIV and STDs, there are not significant racial and ethnic disparities in 
HCV diagnoses. In 2016, 89% of people diagnosed were non-Hispanic white, 4% of people were 
Hispanic, 5% were African American/Black, 1% were Asian, and less than 1% were other races. 
• People 30 and Under Diagnosed with HCV: There were 347 people 30 years of age and under 
reported as diagnosed with HCV in 2016, accounting for 15% of all diagnoses. This increase 
continues a trend observed since reporting began. Among those 30 and younger, 35% were 
between the ages of 20 and 24, and 55% were between 25 and 30 years old. An analysis of 
surveillance data indicated that, of the 338 people 30 and under who were eligible for follow up, 
68% of people reported injection drug use, while 29% reported no injection drug use.  
• Iowans Diagnosed with HCV Since 2000: There have been 23,588 Iowans ever reported to IDPH 
with HCV. Of those people, 516 were reported before the year 2000, so data, including 
demographics, are quite limited. Of the 23,072 people reported to IDPH as diagnosed with HCV 
from 2000 through 2016, 63% were baby boomers (born between 1945 and 1965), 7% were born in 
1986 or later, and 26% were born between 1966 and 1986. Males were about 62% of people 
diagnosed, while females were 36%. Non-Hispanic whites were most likely to be diagnosed (85%), 
followed by African American/blacks (9%), Hispanics (3%), and Asians (1%). It should be noted that 
race and ethnicity information were not reported for 58% of people diagnosed with HCV and 
reported to IDPH since 2000. Two-thirds (67%) of people diagnosed with HCV had evidence of 
chronic infection (i.e. PCR result), while 33% of people were reported with antibody results only.  
• HIV and HCV Co-infection: An analysis of co-infection of HIV and HCV revealed that 361 people had 
been reported to IDPH as having both HIV and HCV. Of those people, 290 (80%) were alive at the 
end of 2016, while 71 were deceased, indicating that 11% of people living with HIV are co-infected 
with HCV. The majority of people who are co-infected, 79%, were males, and white, 65%.  
• Estimate of Total Number of Iowans with HCV: As of December 31, 2016, there were 23,588 
Iowans diagnosed with hepatitis C who were reported to IDPH. Based on this number of reports, 
there are likely 39,215 to 149,173 Iowans with hepatitis C infections, with 17,647 to 126,797 of 
these people undiagnosed.  
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Organization of the Surveillance Report 
This end-of-year report presents surveillance data on hepatitis C in Iowa. It describes hepatitis C for the 
state and of its population subgroups. There are four sections to the report: Section 1 describes data 
sources; Section 2 is a narrative summary with key highlights; Section 3 employs charts, graphs, and 
tables to illustrate trends; and Section 4 outlines the reporting requirements for hepatitis C in Iowa. 
 
Definitions 
Hepatitis C diagnoses reflect all persons diagnosed with HCV for the first time, who were residents of 
Iowa at diagnosis. Age is the age at time of first diagnosis of HCV. This includes people reported with 
antibody positive results or confirmatory (RNA) results.  
 
Confirmed case of chronic HCV infection means the person has HCV RNA circulating in his or her 
blood, confirmed by laboratory testing.  
 
HCV antibody positive case means that there is a presence of antibodies to HCV within a person’s 
blood. It indicates a person was exposed to HCV and became infected, but approximately 15 to 25% of 
people will spontaneously clear the virus without treatment. Therefore, 75 to 85% of people with 
positive antibody tests will be chronically infected.  
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 Section 1:  SOURCES OF DATA 
Core HCV Surveillance Data 
Iowa Disease Surveillance System (IDSS) 
HCV data are collected in the Iowa Disease Surveillance System, which is a web-based system designed 
to facilitate reporting, investigation, and surveillance of communicable diseases in Iowa. HCV is a 
reportable disease as defined by Iowa Code Chapter 139A. Reports of HCV infection are submitted by 
local public health, private providers, laboratories, and others. IDSS is not a static database, as cases 
can be updated daily. Some records had incomplete data, which was a limitation of analysis. It is also 
unknown who has been cured of their HCV, or who has cleared the infection on their own.   
Hepatitis C test results in IDSS were defined as screening or confirmatory by the following criteria:  
Screening tests: (usually reported as positive or negative) 
• HCV Antibody Signal/Cutoff by EIA antibody (See Interpretation & Numeric Result in lab report) 
• Serology – HCV antibody (EIA) (positive, negative, equivocal, or not reactive) 
• Serology – Anti-HCV antibody test (positive, negative, equivocal, or not reactive) 
• Serology – HCV IgG antibody (EIA) (positive, negative, equivocal, not reactive, or See 
Interpretation & Numeric Result) 
• Serology – HCV IgM antibody (EIA) (positive, negative, equivocal, not reactive, or See 
Interpretation & Numeric Result in lab report) 
Confirmatory tests:  
• Polymerase Chain Reaction (PCR) (detected, equivocal, indeterminate, not detected, not 
quantified, or not tested) 
• Genotype (detected, not detected, or indeterminate) 
• Serology – RNA Qualitative (QL) (positive, negative, equivocal, or not reactive) 
• Serology – HCV RIBA (antibody test – does not indicate current infection) (negative or positive) 
• Serology – HCV RNA (positive, negative, or not done) 
• Serology – HCV DNA QL Log (positive, negative, equivocal, or indeterminate) 
 
Diagnosis Date and Completeness of Surveillance Data 
Only persons reported in Iowa and for whom last name, date of birth, sex, and date of diagnosis are 
known are included in this report. Evaluations of the surveillance system indicate that potentially 
significant numbers of Iowans with HCV may have never been reported to IDPH. In addition, these data 
do not include people who have contracted the virus, but who have not been diagnosed. Nationally, 
CDC estimates that 45 to 85% of people with HCV are undiagnosed.  
 
Co-infection with HIV and HCV 
Co-infections were determined by a match between IDSS and the Iowa electronic HIV/AIDS Reporting 
System (eHARS), and were supplemented by data from three Ryan White-funded clinics. All HIV-
infected persons who were first diagnosed while living in Iowa, or who have lived in Iowa at some point 
in time while infected with HIV, or who have accessed care at an Iowa facility and have been reported 
to IDPH, are included in eHARS. All reports of HCV infection as of 12/31/2016 were matched to HIV 
reports in eHARS as of 12/31/2016. Matches were based on date of birth, last name, and Soundex of 
first name. Persons with infection reported in both databases were considered to be co-infected.  
 
Population Data 
The surveillance program has used the 2016 population estimates from the U.S. Census Bureau 
(http://www.census.gov) to calculate prevalence rates.  
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  Section 2:  NARRATIVE SUMMARY 
  
Iowans Diagnosed with Hepatitis C in 2016 
There were 2,287 Iowans diagnosed with hepatitis C (HCV) in 2016, up 52 (2%) from 2,235 in 2015, and 
252 (12%) over the average of 2,035 for the previous five years (2000 through 2015). As seen in Figure 
3.1, the annual number of people diagnosed with HCV has continued to increase steadily since 2000. 
The 2,287 people diagnosed with HCV in 2016 is the largest number ever recorded in a single year in 
Iowa since reporting began. Seventy percent of people diagnosed in 2016 had evidence of a 
confirmatory (PCR) test.  
  
Sex 
In 2016, 63% of Iowans diagnosed with HCV were males. However, an analysis of people 30 and 
younger reported with HCV reveals that the distribution is more even, with males being 52% of 
diagnosed people. 
 
Birth Cohort 
Fifty-five (55) percent of people diagnosed with HCV in 2016 were baby boomers, or those born 
between 1945 and 1965, while 15% were people born after 1986 (30 years of age and younger). About 
30% of people diagnosed in 2016 were born between 1966 and 1985 (between the ages of 31 years old 
and 50 years old). A significantly smaller percentage (2%) of people reported with HCV in 2016 were 
born before 1945. 
 
Ethnicity and Race  
Unlike HIV and STDs, there are not significant racial and ethnic disparities in HCV diagnoses. In 2016, 
89% of people diagnosed were non-Hispanic white, 4% of people were Hispanic, 5% were black/African 
American, 1% were Asian, and less than 1% were other races. 
 
Iowans 30 Years of Age and Under Diagnosed with Hepatitis C in 2016 
There were 347 people 30 years of age and under reported as diagnosed with HCV in 2016, accounting 
for 15% of all diagnoses. This increase continues a trend observed since reporting began. Among those 
30 and younger, 35% were between the ages of 20 and 24, and 55% were between 25 and 30 years 
old. An analysis of surveillance data indicated that, of the 338 people 30 and under who were eligible 
for follow up, 68% of people reported injection drug use, while 29% reported no injection drug use. 
 
Iowans Ever Reported with HCV 
There have been 23,588 Iowans ever reported to IDPH with HCV. Of those people, 516 were reported 
before the year 2000, so data, including demographics, are quite limited. Of the 23,072 people 
reported to IDPH as diagnosed with HCV from 2000 through 2016, 63% were baby boomers (born 
between 1945 and 1965), 7% were born in 1986 or later, and 26% were born between 1966 and 1986. 
Males were about 62% of people diagnosed, while females were 36%. Regarding age at diagnosis, the 
percentages of persons diagnosed who were 30 and younger or between 31 and 40 years old have 
increased substantially since 2000. Non-Hispanic whites were most likely to be diagnosed (85%), 
followed by African American/blacks (9%), Hispanics (3%), and Asians (1%). It should be noted that race 
and ethnicity information were not reported for 58% of people ever diagnosed with HCV and reported 
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to IDPH since 2000. Two-thirds (67%) of people diagnosed with HCV had evidence of chronic infection 
(i.e. PCR result), while 33% of people were reported with antibody results only. 
Deaths of Persons with Hepatitis C 
Since 2000, the number of Iowans dying from hepatitis C-related causes has increased. There were 
1,113 Iowans who died from hepatitis C-related causes between 2000 and 2016, meaning that 
hepatitis C virus was listed on the death certificate. Mortality from hepatitis C is likely underestimated, 
as death certificates often underreport HCV infection, and many people with HCV are undiagnosed.    
 
HIV and HCV Co-infection 
An analysis of co-infection of HIV and HCV revealed that 361 people had been reported to IDPH as 
having both HIV and HCV. Of those people, 290 (80%) were alive at the end of 2016, while 71 were 
deceased, indicating that 11% of people living with HIV are co-infected with HCV. The majority of 
people who are co-infected, 79%, were males, and white, 65%.  
 
Estimation of Prevalence of HCV in Iowa 
As of December 31, 2016, there were 23,588 Iowans diagnosed with hepatitis C who were reported to 
IDPH. Of these people, 15,510 had evidence of chronic infection, while 8,078 had only antibody results 
reported. The Centers for Disease Control and Prevention estimates that 15 to 25% of people with HCV 
clear the infection spontaneously, so it’s likely that 75 to 85% of the 8,078 people with antibody only 
results reported actually have chronic HCV infection. CDC also estimates that 45 to 85% of people with 
HCV have not been diagnosed. Based on these values, IDPH estimates that there are between 39,215 
to 149,173 Iowans with hepatitis C infections, with 17,647 (45%) to 126,797 (85%), of these people 
undiagnosed.  
 
Expanded HCV Surveillance Follow up for 2017 
Since 2015, IDPH has conducted surveillance follow up with healthcare providers of Iowans diagnosed 
with HCV who were 30 years old or under to collect injection drug use behavior information. The cutoff 
age of 30 was chosen because other states were reporting increases in diagnoses in residents 30 and 
under. However, analyses of Iowa’s hepatitis C surveillance data indicate that Iowans 30 to 39 are also 
experiencing increases in diagnoses, potentially associated with the expanding number of people who 
inject drugs related to the opioid epidemic. Therefore, the cutoff age for HCV surveillance follow up 
was increased to 39, effective January 1, 2017.  
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 Section 3:  TABLES AND FIGURES 
 
Table 3.1 Iowans Diagnosed and Reported with Hepatitis C in 2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics People reported with HCV Diagnosis 
 Number (%) 
Sex at Birth   
Male 1,437 (63) 
Female 850 (37) 
Age at Diagnosis   
Under 13  4 (<1) 
13-30 337 (15) 
31-44 469 (21) 
45-64 1,255 (55) 
65 or older 222 (10) 
Birth Cohort Year   
30 and Under (Born 1986 or later) 347 (15) 
Baby Boomers (1945-1965) 1,202 (53) 
Born before 1945 50 (2) 
All other ages (1966-1985) 688 (30) 
Ethnicity/Race   
Hispanic/Latino, All Races 90 (4) 
Not Hispanic, White 2,036 (89) 
Not Hispanic, Black/African American 119 (5) 
Not Hispanic, Asian 26 (1) 
Not Hispanic, Native Hawaiian/Pacific Islander 1 (<1) 
Not Hispanic, American Indian/Alaska Native 11 (<1) 
Not Hispanic, Multi-race 5 (<1) 
Result Type   
Antibody  688 (30) 
Polymerase Chain Reaction (PCR) 809 (35) 
HCV recombinant immunoblot assay (RIBA) 2 <1% 
Genotype 788 (34) 
Case Status   
Confirmed case 1,599 (70) 
Screening (antibody) only 688 (30) 
Co-Infected with HCV   
No 2,237 (98) 
Yes, HIV and HCV Co-infected 50 (2) 
Totals 2,287 (100) 
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Table 3.2 Iowans 30 and Under Diagnosed with Hepatitis C in 2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics People reported with HCV Diagnosis 
 Number (%) 
Sex at Birth   
Male 182 (52) 
Female 165 (48) 
Age at Diagnosis   
Under 13  9 (3) 
13-19 25 (7) 
20-24 121 (35) 
25-30 192 (55) 
Reported Injection Drug Use   
Yes 231 (67) 
No 97 (28) 
Unknown 10 (3) 
Not Assessed (patient under age 13) 9 (3) 
Ethnicity/Race   
Hispanic/Latino, All Races 18 (5) 
Not Hispanic, White 304 (88) 
Not Hispanic, Black/African American 17 (5) 
Not Hispanic, Asian 6 (2) 
Not Hispanic, Native Hawaiian/Pacific Islander 0 0 
Not Hispanic, American Indian/Alaska Native 0 0 
Not Hispanic, Multi-race 2 (<1) 
Case Status   
Confirmed case 249 (72) 
Antibody only 98 (28) 
TOTALS 347 (100) 
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Table 3.3 Iowans Diagnosed with HCV from 2000 through 2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Race and ethnicity data were missing for 58% (n=13,310) of case reports from 2000 through 2016. The 
percentages for racial and ethnic groups were calculated using a denominator of 9,762. 
 
 
 
 
 
 
 
Characteristics People reported with HCV Diagnosis 
 Number (%) 
Sex at Birth   
Male 14,216 (62) 
Female 8,421 (36) 
Other  12 (<1) 
Unknown 423 (2) 
Age at Diagnosis   
Under 13  145 (<1) 
13-30 2,132 (9) 
31-44 4,349 (19) 
45-64 14,393 (62) 
65 or older 2,053 (9) 
Birth Cohort Year   
30 and Under (Born 1986 or later) 1,548 (7) 
Baby Boomers (1945-1965) 14,473 (63) 
Born before 1945 1,047 (5) 
All other ages (1966-1985) 6,004 (26) 
Ethnicity/ Race*   
Hispanic/Latino, All Races 333 (3) 
Not Hispanic, White 8,288 (85) 
Not Hispanic, Black/African American 844 (9) 
Not Hispanic, Asian 136 (1) 
Not Hispanic, Native Hawaiian/Pacific Islander 7 (<1) 
Not Hispanic, American Indian/Alaska Native 118 (1) 
Not Hispanic, Multi-race 36 (<1) 
Result Type   
Antibody  7,662 (33) 
Polymerase Chain Reaction (PCR) 8,524 (37) 
HCV recombinant immunoblot assay (RIBA) 1,025 (4) 
Genotype 5,861 (25) 
Case Status   
Confirmed case 15,410 (67) 
Antibody only 7,662 (33) 
TOTALS 23,072 (100) 
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 Table 3.4 Iowans Co-infected with HIV and HCV 
 
 Characteristics People Co-Infected 
 Number (%) 
Sex at Birth   
Male 285 () 
Female 76 () 
Other  0 (na) 
Birth Cohort Year   
30 and Under (Born 1986 or later) 11 () 
Baby Boomers (1945-1965) 223 () 
Born before 1945 7 () 
All other ages (1966-1985) 120 () 
Ethnicity/ Race*   
Hispanic/Latino, All Races 19 () 
Not Hispanic, White 234 () 
Not Hispanic, Black/African American 84 () 
Not Hispanic, Asian 11 () 
Not Hispanic, Native Hawaiian/Pacific Islander 0 (na) 
Not Hispanic, American Indian/Alaska Native 0 (na) 
Not Hispanic, Multi-race 13 () 
Vital Status (as of Dec. 31,2016)   
Alive 290 () 
Deceased 71 () 
TOTALS 361 (100) 
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The number of people diagnosed with HCV in 2016, 2,287, is 11% more than the 5-year average of 2,035 
(2011 through 2015), and a continuation of yearly increases in diagnoses seen since 2000. There were 
516 diagnoses of HCV among Iowans reported before 2000. 
 
 
 
In order to determine whether a person has chronic HCV infection, a confirmatory (i.e., RNA PCR) test must 
be administered. In 2016, 70% of Iowans reported to IDPH with HCV had evidence of a positive 
confirmatory test, while 30% of Iowans had antibody-only results reported. The proportion of people who 
had evidence of a confirmatory test in 2016 was the highest on record, and in line with increases observed 
during the preceding few years.  
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Figure 3.1: 
Number of Iowans Diagnosed with HCV: 2000 through 2016
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Number of Iowans Reported with Antibody-only or Confirmatory HCV Test 
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Trends in Iowans Diagnosed with Hepatitis C 
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The numbers of Iowans in all age groups diagnosed with HCV since 2000 have increased significantly, but 
rates of increase vary by age range. Overall, diagnoses among people 30 and under and people 61 years 
of age and older have increased most substantially, particularly within the past few years. The number of 
people 30 and under diagnosed in 2016, 347, is 24% more than the 5-year average of 263 (2011 through 
2015). There were 349 Iowans ages 31 to 40 diagnosed in 2016, which is 22% more than the 5-year 
average of 271. The 372 Iowans ages 41 to 50 years old diagnosed in 2016 is 16% higher than the 5-year 
average of 431. The number of Iowans ages 51 to 60 diagnosed in 2016, 761, is 6% more than the 5-year 
average of 717. There were 438 Iowans 61 years of age or older diagnosed in 2016, which was 33% 
higher than the 5-year average of 294.  
 
 
 
There were definite peaks in the ages of Iowans diagnosed with hepatitis C in 2016. Iowans under 40 
diagnosed with HCV represent those who likely contracted the virus from current or recent injection 
drug use and may be transmitting the virus to others, although they are unlikely to have yet experienced 
health complications related to HCV. Iowans older than 50 diagnosed with HCV are at risk for health 
complications, but likely acquired the virus decades ago and are unlikely to transmit. 
0
100
200
300
400
500
600
700
800
900
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
Nu
m
be
r o
f P
er
so
ns
Figure 3.3:
Age at Onset of HCV in Iowans: 2000 through 2016
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Hepatitis C virus disproporionately impacts males. From 2000 through 2016, there were about three 
males diagnosed for every two females diagnosed. It’s important to note that this varies by age. For 
people 30 and under diagnosed with HCV, males and females are almost equally likely to be diagnosed. 
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Figure 3.4:
Iowans Diagnosed with HCV in 2016, by Age
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Figure 3.5
Iowans Diagnosed with HCV by Sex: 2000 through 2016
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The number of Iowans dying from hepatitis C-related causes has generally increased since 2000. 
Between 2000 and 2016, there were 1,113 Iowans who died from hepatitis C-related causes, meaning 
that hepatitis C was listed on the death certificate. Mortality from hepatitis C is likely underestimated, as 
death certificates often underreport HCV infection.    
 
 
 
 
In the United States, it is estimated that 25% of persons with HIV are co-infected with hepatitis C1. Co-
infection with HIV and HCV is particularly common among people who inject drugs. Iowa is a low 
prevalence state for HIV disease. At the end of 2016, there were 2,647 persons living with HIV in Iowa. 
People who inject drugs accounted for 8% of diagnoses in 2014 and 2015, and 3% in 2016. To ascertain 
co-infections of HIV and HCV among Iowans, HIV cases in the HIV surveillance system were matched with 
the HCV surveillance system through 2016. A total of 361 persons were ever reported to IDPH as having 
both HIV and HCV. Of those people, 290 were alive at the end of 2016 and living in Iowa, indicating that 
11% of Iowans with HIV are co-infected with HCV. This is likely an underestimate, as previous analyses 
have indicated that up to half of people co-infected have not been reported to IDPH as being diagnosed 
with HCV. The majority of people who are co-infected, 79%, were males, and white, 65%. 
 
 
 
 
 
 
 
 
 
 
 
                                                 
1 Centers for Disease Control and Prevention. (2015). HIV/AIDS and Viral Hepatitis. Retrieved from www.cdc.gov. 
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Figure 3.6
Hepatitis C-Related Deaths Among Iowans
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This map shows the 23,072 persons reported with HCV from January 1, 2000, through 
December 31, 2016. It indicates counties where persons were living at the time of 
diagnosis.  
 
Ten most populous counties are home to 59% of Iowans who have been reported with 
HCV. 
 
 
 
 
Figure 3.7  
Number of Iowans Diagnosed with HCV from 2000 through 2016,  
by County of Residence at Diagnosis  
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State Average HCV Rate: 739 per 100,000 population 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8  
Rates of HCV per 100,000 Population  
 County of Residence at Diagnosis  
 
This map shows the rates of HCV per county of people diagnosed from January 1, 
2000, through December 31, 2016. It indicates counties where persons were living 
at the time of diagnosis. 
 
Ten most populous counties are home to 59% of Iowans who have been reported 
with HCV. 
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* Indicates one of the 10 most populous Iowa counties 
– County populations are based on the 2016 U.S. Census estimates 
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Figure 3.9
Prevalence of HCV by County of Residence at Diagnosis: Iowans 
Diagnosed with HCV as of December 31, 2016
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Figure 3.10 
Rates of HCV in Iowans Under 30 Years Old per 100,000 Population 
County of Residence at Diagnosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This map shows the rates of HCV per county of Iowans under 30 years old who 
were diagnosed from January 1, 2000, through December 31, 2016. It indicates 
counties where persons were living at the time of diagnosis. 
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Section 4:  REPORTING HCV IN IOWA 
 
 
See http://idph.iowa.gov/hivstdhep/hep for this report. 
All identified forms of viral hepatitis are reportable to the Iowa Department of Public Health (IDPH), 
as mandated by Iowa Code section 139A.3. Due to the infectious nature of each form of viral 
hepatitis, it is necessary that each case be reported so that prevention and control efforts may be 
initiated by IDPH. 
 
What laboratory results should be reported? 
1. Screening tests: 
a. Anti-HCV: Positive or reactive 
2. Confirmatory Testing: 
a. HCV RNA, NAT, or PCR: Positive or reactive test results 
b. HCV RNA, NAT, or PCR: Negative or not detected test results 
c. Genotyping: Detected or not detected results 
 
Both medical providers who make these diagnoses and laboratories who find positive results for 
these infections are required to report. Many laboratories now have automated processes (e.g., 
Electronic Laboratory Reporting) to report their results. The technology for automated reporting 
from medical providers is not fully developed at this time. 
 
The most common method of reporting by medical providers is by completing the form titled, 
“Iowa Disease Reporting Card” located at this link. The form may be faxed in to the number located 
at the top of the form. For questions related to reporting of hepatitis C, please contact: Shane 
Scharer, Hepatitis Data Coordinator at (515) 281-5027. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
IOWA DISEASE REPORTING CARD                   FAX VERSION 
Disease reporting is required by Iowa Administrative Code [641]-1 (139A) 
Fax report to (515) 281-5698 or call (800) 362-2736 
DISEASE AND LABORATORY INFORMATION 
DISEASE/EVENT:       Laboratory: 
 
      
Diagnosis date: 
 
     /     /      Lab city/state/zip: 
 
      
Onset date:      /     /      Collection date: 
 
     /     /      
Outcome: 
Survived this illness    Died from this illness 
Died unrelated to this illness   Unknown Specimen source:       
Provider name:  Lab test:  
Provider title: ARNP     DO     MD     NP     PA Result date:      /     /      
Facility name:       Result: 
Positive/detected   
Negative/undetected   
Undetermined   
Equivocal   
Address:             
Other:  
 
Phone : (     )        -      City/State/Zip:       
Clinical sx: 
Abdominal pain 
Anorexia 
Bull’s eye rash 
Cough 
Diarrhea 
Fever     
Gland swelling 
Jaundice 
Rash 
Sore throat 
Stiff neck    
Vomiting 
Other:   
                                    Specimen sent to UHL  
PATIENT INFORMATION 
Name (last, first, middle):       
Address:       
City:       County:       Zip:       
Long-term care     
resident: Yes     No     Unk Facility name:       
DOB:       /       /       Age:       Years   Months Gender: M  F  Unk 
Pregnant? Yes  No  Unk Due Date:      /     /      
Race: 
White 
Black or African American 
American Indian or Alaska Native 
Hawaiian or Pacific Islander 
Asian 
Unknown       Other 
 Marital 
status: 
Single   
Married   
Widowed   
Unknown  
Divorced   
Ethnicity: Hispanic or Latino   Not Hispanic or Latino   Unknown 
If minor, Parent name(s):       
Phone: Home (       )              -      Work (       )              -      Other (       )              -      
OCCUPATION INFORMATION 
Job title: 
 
      Facility name: 
 
      
Worked after 
symptom onset: 
 
Yes     No     Unknown Address: 
 
      
Handle food: 
Attend or provide child care: 
Attend school: 
Work in a lab setting: 
Yes     No     Unknown 
Yes     No     Unknown 
Yes     No     Unknown 
Yes     No     Unknown 
Zip code: 
 
      
City/State/County: 
 
      
Work in a health care setting: 
Direct patient care duties in lab 
or health care setting: 
Health care worker type: 
Yes     No     Unknown 
                          
Yes     No     Unknown 
      
Phone:  (     )           -              Type: 
 
 
 
HOSPITALIZATION INFORMATION 
Was the case 
hospitalized? 
 
 Yes    No    Unknown Hospital: 
 
      
Admission date: 
 
     /     /      
 
Discharge date: 
 
     /     /        Still hospitalized 
 
Days hospitalized: 
 
    
REPORTER INFORMATION 
Reporter name:  Reporter facility name:  
Reporter phone:  Date reported to IDPH:  
Comments: 
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